脆性x综合征(FXS)是遗传性智力低下的常见原因,主要由FMR1基因突变导致(CGG)n序列异常扩增(n〉200)引起。但是,FMR1基因前突变(n=55-200)也可引起一系列的临床表现,其机制与FXS完全不同,为mRNA毒性机制。在1991年FMR1基因发现后的几年内,学者们普遍认为前突变携带者在临床上没有受累,只是女性携带者的CGG序列在遗传过程中可能发生扩增,导致子女患FXS。因此,临床医师很少注意前突变相关疾病,并且对于前突变和FXS之间的关系和区别普遍缺乏认识。现对FMR1基因前突变相关的临床表现、神经病理学和分子机制进行综述。
Fragile X syndrome (FXS) is one of the common causes of inherited intellectual disability. It is mainly caused by the mutation of FMR1 gene which lead to (CGG) n abnormal amplification (n 〉 200). However, the FMR1 gene premutation ( n = 55 - 200 ) can cause a series of clinical manifestations through an entirely distinct molecular mechanism from FXS,which involved increased FMR1 mRNA toxicity. A few years after the discovery of the FMR1 gene in 1991 ,it was generally believed that the carriers of premutation were clinically unaffected,but female car- riers of premutation had children with FXS. Thus, a few doctors pay attention to these disorders and generally lack of awareness the difference between the premutation and FXS. A review of the clinical manifestations, neuropathology and molecular mechanisms will show in the following paper.